Rana Malek is an Endocrinology/Metabolic physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 72 publications with 1,458 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.1%Insulin Analog17.3%Lantus Solostar29%Novolog Flexpen26%Basaglar Kwikpen U-10025%Novolog12%Humalog Kwikpen U-1009%Part D<11 patientsGLP-1 receptor agonist14.8%Ozempic51%Trulicity38%Rybelsus11%Part D<11 patients+ 5 more classes in this area
Cardiovascular
25.8%Statin9.2%Atorvastatin Calcium65%Simvastatin19%Rosuvastatin Calcium17%Part D<11 patientsAngiotensin receptor blocker (ARB)3%Losartan Potassium100%Part D≥14 patients+ 8 more classes in this area
Hormonal (systemic)
14.4%l-Thyroxine8.7%Levothyroxine Sodium100%Part D≥27 patientsThyroid Hormone Synthesis Inhibitor3.2%Methimazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A safety review of approved oral agents for treating type 2 diabetes and associated diseases in pregnant patients
Expert Opinion on Drug Safety
2025 - Cost Effectiveness of Definitive Treatment Strategies for Autonomously Functioning Thyroid Nodules
Clinical Endocrinology
2024 - Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology
Current Opinion in Oncology
2024 - Improving Access to Eye Care Through Community Health Screenings Using Artificial Intelligence
Ophthalmic Epidemiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”